Clinical trial · Observational
Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Polycystic ovary syndrome (PCOS) is one of the most common disease caused by hormonal imbalance and is also associated with overweight and obesity. It affects 5-10% of adolescent girls and women capable of having children. Polycystic ovary syndrome is associated with missed menstrual periods, hormonal imbalance, being overweight, and with a form of diabetes. Girls with polycystic ovary syndrome may have a breathing problem known as "sleep apnea." Sleep apnea may cause a person to stop breathing for short periods of time while sleeping. People with polycystic ovary syndrome are thirty times more likely to develop sleep apnea than those who do not have PCOS. If sleep apnea is not treated, it may lead to daytime sleepiness, poor school performance, high blood pressure, heart disease and diabetes. The purpose of this study is to understand how insulin function is affected in presence of sleep apnea in girls with polycystic ovary syndrome between 13-21 years of age as compared to girls with PCOS without sleep apnea. Insulin is one of the hormones made in your body to convert food into energy. In people with increase weight body cannot use insulin properly. The investigators also want to see if insulin action is also affected by sleep apnea.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Obstructive Sleep Apnea Syndrome | — | UNRESOLVED | — |
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
| Sleep Apnea | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Nasal Continuous positive airway pressure (CPAP) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (5)
- label
- Obese PCOS and sleep apnea
- description
- BMI \>95%ile AND Polysomnography with AHI \>2.5 Will initiate Nasal Continuous positive airway pressure (CPAP)
- interventionNames
- Device: Nasal Continuous positive airway pressure (CPAP)
- label
- Obese PCOS without sleep apnea
- description
- BMI \>95%ile AND Polysomnography with AHI \<2.5
- label
- Normal weight Controls
- description
- BMI \<85%ile AND regular menses
- label
- Lean PCOS and sleep apnea
- description
- BMI \<85%ile AND Polysomnography with AHI \>2.5 Will initiate Nasal Continuous positive airway pressure (CPAP)
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 13 Years
- Maximum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Female. * Ages 13-21 * PCOS * BMI \>95%ile (Obese group) or \<85%ile (Lean group) * Controls: ages 18-21, regular menses, BMI \<85%ile Exclusion Criteria: * Breastfeeding. * Pregnant. * Use of any steroid preparations (including hormonal contraception), medications known to alter insulin secretion and/or action within 3 month (including Metformin)
References
Publications (0)
Data not yet available